Mycophenolate mofetil for autoimmune cytopenias in children: high rates of response in inborn errors of immunity

Second-line treatments of autoimmune cytopenias (AC) are not well-defined in children. Mycophenolate mofetil (MMF) is an immunosuppressant agent that has been demonstrated to be safe and effective in this setting. A retrospective observational study was conducted in 18 children with prolonged AC who...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Rubén Berrueco, Elisa González-Forster, Angela Deya-Martinez, María Solsona, Ana García-García, Joan Calzada-Hernández, Luo Yiyi, Alexandru Vlagea, Anna Ruiz-Llobet, Laia Alsina
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2023-10-01
Σειρά:	Frontiers in Pediatrics
Θέματα:	pediatrics autoimmune hemolytic anemia autoimmune thrombocytopenia Evans syndrome autoimmune diseases mycophenolate mofetil
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fped.2023.1174671/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!